Literature DB >> 11704500

Identification of the type II Na(+)-Pi cotransporter (Npt2) in the osteoclast and the skeletal phenotype of Npt2-/- mice.

A Gupta1, H S Tenenhouse, H M Hoag, D Wang, M A Khadeer, N Namba, X Feng, K A Hruska.   

Abstract

We previously reported that a type II sodium phosphate (Na(+)-Pi) cotransporter (Npt2) protein is expressed in osteoclasts and that Pi limitation decreases osteoclast-mediated bone resorption in vitro. We also demonstrated that mice homozygous for the disrupted Npt2 gene (Npt2-/-) exhibit a unique age-dependent bone phenotype that is associated with significant hypophosphatemia. In the present study, we sought to identify the Npt2 cDNA in mouse osteoclasts and characterize the impact of Npt2 gene ablation on osteoclast function and bone histomorphometry. We demonstrate that the osteoclast Npt2 cDNA sequence is identical to that of the proximal renal tubule and, thus, not an isoform or splice variant thereof. Histomorphometric analysis revealed that, at 25 days of age, Npt2-/- mice exhibited a reduction in osteoclast number and eroded perimeters, relative to wild-type mice. Moreover, although the number of metaphyseal trabeculae was reduced in 25-day-old Npt2-/- mice, trabecular bone volume was normal due to increased trabecular width. At 115 days of age, the decrease in osteoclast index persisted in Npt2-/- mice relative to wild-type littermates. However, mineralizing and osteoblast surfaces and bone formation rates were increased, and, although trabecular number was still reduced, trabecular bone volume was higher than that of wild-type mice. These data demonstrate a link between osteoclast activity and trabecular development in young Npt2-/- mice, and suggest that an age-related adaptation to Npt2 deficiency is apparent in osteoclast and osteoblast function and bone formation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704500     DOI: 10.1016/s8756-3282(01)00601-9

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  20 in total

1.  Expression of renal and intestinal Na/Pi cotransporters in the absence of GABARAP.

Authors:  Sonja C Reining; Annette Liesegang; Heinrich Betz; Jürg Biber; Heini Murer; Nati Hernando
Journal:  Pflugers Arch       Date:  2010-03-31       Impact factor: 3.657

Review 2.  Expression and function of Slc34 sodium-phosphate co-transporters in skeleton and teeth.

Authors:  Laurent Beck
Journal:  Pflugers Arch       Date:  2018-12-03       Impact factor: 3.657

3.  Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background.

Authors:  Qisheng Tu; Min Pi; Gerard Karsenty; Leigh Simpson; Shiguang Liu; L Darryl Quarles
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 4.  Cooperative electrogenic proton transport pathways in the plasma membrane of the proton-secreting osteoclast.

Authors:  Miyuki Kuno
Journal:  Pflugers Arch       Date:  2018-03-17       Impact factor: 3.657

5.  Pharmacological Npt2a Inhibition Causes Phosphaturia and Reduces Plasma Phosphate in Mice with Normal and Reduced Kidney Function.

Authors:  Linto Thomas; Jianxiang Xue; Sathish Kumar Murali; Robert A Fenton; Jessica A Dominguez Rieg; Timo Rieg
Journal:  J Am Soc Nephrol       Date:  2019-08-13       Impact factor: 10.121

6.  Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin.

Authors:  Peter S N Rowe; Naoko Matsumoto; Oak D Jo; Remi N J Shih; Jeannine Oconnor; Martine P Roudier; Steve Bain; Shiguang Liu; Jody Harrison; Norimoto Yanagawa
Journal:  Bone       Date:  2006-06-09       Impact factor: 4.398

Review 7.  Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.

Authors:  Peter S N Rowe
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2012       Impact factor: 1.807

8.  Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.

Authors:  Aline Martin; Valentin David; Jennifer S Laurence; Patricia M Schwarz; Eileen M Lafer; Anne-Marie Hedge; Peter S N Rowe
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

9.  Renal phosphaturia during metabolic acidosis revisited: molecular mechanisms for decreased renal phosphate reabsorption.

Authors:  Marta Nowik; Nicolas Picard; Gerti Stange; Paola Capuano; Harriet S Tenenhouse; Jürg Biber; Heini Murer; Carsten A Wagner
Journal:  Pflugers Arch       Date:  2008-06-06       Impact factor: 3.657

10.  Na+/H+ exchanger regulatory factor 1 (NHERF1) directly regulates osteogenesis.

Authors:  Li Liu; Veronica Alonso; Lida Guo; Irina Tourkova; Sarah E Henderson; Alejandro J Almarza; Peter A Friedman; Harry C Blair
Journal:  J Biol Chem       Date:  2012-10-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.